TNNI3 and Schnyder corneal dystrophy: Moreover, compared with individuals in the low (5‐year risk <4%) or intermediate (5‐year risk within 4%‐6%) risk groups, concentrations of cTnI elevated significantly in patients in the high‐risk group of SCD (5‐year risk >6%) (Figure 2C).